SUMMARY
SUMMARY
We have studied the effects of flumazenil on sleep time and EEG in rats anaesthetized with 1 Benzodiazepines are used often in association with general anaesthesia. The benzodiazepine receptor is part of the GABA A -receptor, which includes the GABA-binding sites, barbiturate binding sites and Cl" channels [1, 2] . Benzodiazepines and barbiturates increase GABA-induced Cl" conductance. The sites of action of volatile anaesthetics are unknown, although they have been reported to interact with lipid bilayers and with proteins of neural membranes [3] . Halothane [4, 5] and propofoi [6] [7] [8] [9] have been reported to modify the efficacy of the inhibitory effect of GABA on neurotransmission. Flumazenil is a specific benzodiazepine receptor antagonist which inhibits central effects of agonists and inverse agonists by competitive interaction at the receptor [10] . However, investigators have reported agonistic and inverse agonistic actions of flumazenil [11, 12] .
In this study, we have investigated the role of the benzodiazepine receptor in general anaesthesia by examining the effects of flumazenil on sleep time and EEG in rats anaesthetized with halothane, thiamylal and propofoi; the interactions of diazepam and anaesthetics; the effects of flumazenil on these interactions; and any agonistic or inverse agonistic effects of flumazenil on behaviour and EEG.
MATERIALS AND METHODS
The study was approved by our Institutional Animal Care Committee. We studied Wistar male rats (200-280 g); standard rat food and water were provided ad libitum up to the time of the experiment. The animals were kept under standard conditions of temperature (22 ±2 °C) and relative humidity, in a non-reversed light-darkness cycle of 12-12 h. Each animal was anaesthetized with halothane and a cannula (0.8 mm o.d.) filled with normal saline was placed in the femoral vein for administration of drugs. Rats were subjected to the studies at least 1 h later.
Animals were allocated to nine groups of 40 rats each, according to agent. Each group consisted of four subgroups of 10 rats, according to the dose of flumazenil: control rats (flumazenil only) or flumazenil 0 (solvent), 0.3, 3 and 30 mg kg" 1 . Three different concentrations of flumazenil (6, 3 and 0.3 mg ml" 1 ) were prepared by dissolving the powdered drug with equal volumes of propylene glycol and polyethylene glycol 400. The 6-mg ml" 1 solution was used for administering 30 mg kg" 1 and the other solutions for 3 and O.Smgkg" 1 . The volumes administered were 5 ml kg" 1 at a dose of 30 mg kg" 1 and 1 ml kg" 1 at 3 and 0.3 mg kg"
1
. The effects of solvent were studied with different volumes (1 and 5 ml kg" 1 ) in five rats each. Thiamylal was dissolved with distilled water to concentrations of 30 and 27 mg ml" 1 . Concentrations of diazepam and propofoi solutions were 5 and 10 mg ml" 1 , respectively. 1 was used in the initial study, but produced a longer period of sleep compared with other agents; therefore we added a thiamylal 27 mg kg" 1 group. Flumazenil was administered 5 min after administration of the i.v. agents or 5 min before discontinuation of halothane. Effects of flumazenil on sleep time and behaviour were investigated during anaesthesia with anaesthetic agents alone and with combinations of anaesthetic agents and diazepam 5 mg kg" 1 (table I) . The sleep time was measured as the interval from the time of i.v. administration of drug or discontinuation of halothane exposure to the time when the rat lifted its head. Rectal temperature was monitored and maintained at 36.5-38.5 °C using radiant heat.
Flumazenil-induced EEG changes were studied in two rats in each group. The animals were anaesthetized with halothane and three stainless steel screws, 1 mm diameter, were placed in the skull: one for grounding and the other two for EEG electrodes. The screws were soldered to a small socket, which was fixed to the skull with dental cement. After 3 days recovery, the rates were subjected to the drug study. The EEG was recorded on a polygraph (Sanei, Tokyo) at a paper speed of 10 mm s" 1 .
Statistics
The effect of flumazenil on sleep time was analysed using one-way analysis of variance (ANOVA) and the Newman-Keuls test. P < 0.05 was considered significant. Values are expressed as mean (SD).
RESULTS

Behavioural observations
Solvent and flumazenil 0.3 and 3 mg kg" 1 , had no effect. Flumazenil 30 mg kg" 1 induced a rigid posture, consisting of extended hind limbs and erect tail, which lasted for 10-30 min. Rats became anaesthetized immediately after i.v. diazepam 10 mg kg" 1 , thiamylal 30 and 27 mg kg" 1 , and propofol 20 mg kg"
1 . The antagonism of diazepam by flumazenil was complete and the rats moved freely immediately after or during, administration of flumazenil 0.3, 3 or 30 mg kg"
1 . Flumazenil had no immediate effect on behaviour in rats anaesthetized with halothane, thiamylal or propofol.
During recovery from anaesthesia, rats in different groups showed different patterns of activities. After halothane anaesthesia, rats moved freely immediately after opening the eyes and lifting the head. The interval from head lifting to recovery of the righting reflex was short (68 (SD 44) s) after propofol, but longer (361 (288) s) after thiamylal 30 mg kg"
1 . Increased chewing activity, which appeared before head lifting, was seen in the diazepam group. Although no re-anaesthetized state was noted after recovery from diazepam, it appeared after combinations of propofol, diazepam and flumazenil 30 mg kg" 1 , after recovery of head lifting.
Sleep time
The sleep times induced by different drugs and their modifications by diazepam and flumazenil are summarized in table II. All doses of flumazenil wakened rats given diazepam immediately (P < 0.001 vs solvent). In contrast, flumazenil had no effect on the sleep time of halothane or thiamylal. Flumazenil 0.3 and 3 mg kg" 1 had no effect on propofol sleep time, but flumazenil 30 mg kg" 1 prolonged it significantly {P < 0.001 vs solvent).
The sleep times of different drugs, which were made similar by adjusting the doses, were prolonged differently with the same dose of diazepam: 6138 s with thiamylal, 2478 s with halothane and 2893 s with propofol {P < 0.001 thiamylal vs halothane or propofol). The efficacy of flumazenil in antagonizing the action of diazepam differed with each drug. For halothane, the smallest dose of 0.3 mg kg" 1 antagonized diazepam completely; for thiamylal, flumazenil 30 mg kg" 1 did not antagonize diazepam completely. In the propofol group, the effect was dose-related and flumazenil 30 mg kg" 1 antagonized diazepam almost completely.
EEG
Flumazenil 0.3 or 3 mg kg" 1 had no effect on EEG. Flumazenil 30 mg kg" 1 decreased the frequency from 12-18 Hz to 5-9 Hz and increased the amplitude from 40-60 uV to 50-110 \iV for about 30 min ( fig.  1 ). Diazepam 10 mg kg" 1 decreased the frequency to 6-10 Hz and increased the amplitude to 50-120 nV; these changes were antagonized immediately by flumazenil. Thiamylal 27 and 30 mg kg" 1 produced burst suppression and then high amplitude (80-180 \iV) and low frequency (4-5 Hz) EEG, on which flumazenil had no effect. Propofol 20 mg kg" 1 pro- duced rhythmic 5-7 Hz, 80-100 uV waves during injection, followed by an almost flat EEG with occasional 4-6 Hz, 10-20 uV waves. Successive changes in EEG were: development of sharp waves of 60-120 uV, increased incidence of sharp waves, burst suppression and high amplitude (80-120 uV) 8-12 Hz waves. Flumazenil had no effect on EEG changes induced by propofol. The addition of diazepam 5 mg kg" 1 shifted the EEG changes of thiamylal and propofol to those associated with deeper stages of anaesthesia. High amplitude, slow wave EEG changed to burst suppression and occasional sharp waves with thiamylal, and to almost isoelectric waves with diazepam. With propofol, diazepam decreased the incidence of sharp waves. These shifts induced by diazepam were antagonized by flumazenil. .,.
DISCUSSION
At a dose of 0.3 mg kg" 1 , flumazenil antagonized completely diazepam-induced behavioural and EEG changes in rats. In contrast with its action on diazepam-induced changes, flumazenil had no antagonistic effect on the behavioural and EEG changes induced by halothane, thiamylal or propofol.
The interactions of flumazenil and anaesthetics observed in the present study reflect both pharmacodynamic and pharmacokinetic factors. Measurements of blood concentrations of anaesthetics are required to assess pharmacokinetic factors in the antagonistic actions of flumazenil on sleep time and EEG. Flumazenil has a short duration of action, which may explain the failure of flumazenil to antagonize general anaesthesia. However, flumazenil 30 mg kg" 1 (100 times greater than that which antagonized the effects of diazepam) did not antagonize general anaesthesia.
Conflicting data have been reported on the interaction of flumazenil with anaesthetics. Acceleration of recovery from halothane anaesthesia has been reported in both mice [13] and humans [14] , but no effects were confirmed on the MAC of halothane [13, 15] , enflurane [16] or isoflurane [16] . The sleep time of methoxyflurane was not affected by flumazenil [17] . Spinal cord and brain electrical activity studies have demonstrated absence of flumazenil interaction with pentobarbitone [18] . Roald, Forsman and Steen [19] reported that flumazenil reversed partially the isoflurane-induced depression of cerebral oxygen consumption and EEG changes, while Schwartz and colleagues [20] reported an opposite view, that flumazenil decreased the MAC of isoflurane in dogs. The present results confirm that flumazenil does not antagonize halothane, thiamylal or propofol anaesthesia. These results indicate that general anaesthesia with these agents is not mediated through benzodiazepine receptors. Barbiturates have been reported to increase the affinity of these receptors for benzodiazepines [1, 21, 22] . However, no endogenous benzodiazepine-like substance has been detected, and an antagonistic effect of flumazenil in thiamylal anaesthesia was absent in this study. These findings suggest that the contribution of the benzodiazepine receptor may be insignificant in barbiturate anaesthesia if benzodiazepines are not co-administered.
Diazepam prolonged the sleep time of thiamylal, propofol and halothane to a greater extent than expected by a simple summation of the sleep time of diazepam and those of the individual anaesthetics. The prolongation of thiamylal sleep time was greater than those of halothane and propofol. The smallest dose of flumazenil, 0.3 ml kg" 1 , antagonized diazepam during emergence from halothane anaesthesia in a manner similar to that when diazepam was administered alone. This result probably indicates that diazepam was simply additive to the action of halothane.
The flumazenil-induced antagonism of diazepam was, however, modified by thiamylal and propofol, and a greater dose was required to antagonize the drug. In the case of thiamylal, a dose of 30 mg kg" 1 (100 times that required to antagonize unanaesthetized rats) was not sufficient. The same dose of flumazenil was required in the case of propofol and the antagonism showed a dose-related response manner. Barbiturates bind to barbiturate receptors, which are part of a supramolecular structure that include benzodiazepine receptor, GABA-binding sites and Cl" channels [1, 2] . Barbiturates increase the affinity of the GABA-binding site for GABA, directly open Cl" channels (at a high dose), and increase the duration of the open state of Cl" channels [23] . Benzodiazepines increase the frequency of opening of Cl" channels by increasing the affinity of GABA-binding sites for GABA [24] . The combination of barbiturates and benzodiazepines increases both the frequency and the duration of open states of Cl" channels, increases Cl" influx and depresses excitabilities of neural membrane. Barbiturates affect the function of the benzodiazepine receptor and facilitate the affinity of benzodiazepines for their receptors [1, 21, 22] . The present study indicated that thiamylal modified the interaction of flumazenil and diazepam. The modification may be exerted, at least partly, through their actions on the GABA-benzodiazepine receptor-Cl" channel complex. The mechanism of modification is beyond the scope of the present study.
An interesting finding of this study was the interaction of flumazenil with propofol. Flumazenil 0.3 and 3 mg kg" 1 had no effect on the action of propofol, but 30 mg kg" 1 prolonged sleep time. Furthermore, although the prolongation of propofol sleep time by diazepam was similar to that by halothane, it required a greater dose of flumazenil to antagonize diazepam in the case of propofol compared with halothane. All these findings combined together indicate a possibility that a large dose of propofol activates, at least in part, the benzodiazepine receptor.
An agonist-like effect of flumazenil was reported previously in animal behaviour [11] and GABAinduced Cl" conductance [12] . A similar agonist-like action was noted also in the present study: a large dose of flumazenil (30 mg kg" 1 ) prolonged the sleep time of propofol, slowed the EEG activity and induced behavioural suppression. However, such an agonist-like action was not confirmed in the case of halothane and barbiturate anaesthesia.
Frequently, intraoperative supplementation with diazepam prolongs recovery from anaesthesia. The present study has shown that the antagonizing effects of flumazenil on the potentiating action of anaesthetics by diazepam were modified, depending on the anaesthetic agent used. Flumazenil did not always reverse the effects of diazepam.
